Evidence map›Paper›PMID 31934227›Full record

ArticleThe Pan African medical journal2019

[Characteristics of chronic lymphocytic leukemia in Togo].

Essohana Padaro, Yao Layibo, Irénée Délagnon Messanh Kueviakoe, Kossi Agbétiafa, Hèzouwè Magnang, Nicole Delali Akossiwa Koudokpo, Koffi Mawussi, Ahoefa Vovor

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in The Pan African medical journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 72% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Essohana PadaroService d'Hématologie, CHU Campus, Université de Lomé, Lomé, Togo.
Yao LayiboService d'Hématologie, CHU Sylvanus Olympio, Université de Lomé, Lomé, Togo.
Irénée Délagnon Messanh KueviakoeService d'Hématologie, CHU Sylvanus Olympio, Université de Lomé, Lomé, Togo.
Kossi AgbétiafaService d'Hématologie, CHU Campus, Université de Lomé, Lomé, Togo.
Hèzouwè MagnangService d'Hématologie, CHU Campus, Université de Lomé, Lomé, Togo.
Nicole Delali Akossiwa KoudokpoService d'Hématologie, CHU Campus, Université de Lomé, Lomé, Togo.
Koffi MawussiService d'Hématologie, CHU Kara, Université de Kara, Togo.
Ahoefa VovorService d'Hématologie, CHU Sylvanus Olympio, Université de Lomé, Lomé, Togo.
University of Lomé · TGCentre Hospitalier Universitaire de Tokoin · TGUniversity of Kara · TG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The epidemiological, clinical and biological characteristics of chronic lymphocytic leukemia (CLL) are little studied in Togo. The purpose of this study was to describe these characteristics at the time of diagnosis. We conducted a retrospective and descriptive study of patients diagnosed at the University Hospital Campus from January 1999 to December 2018. Over the past two decades, 87 patients were seen for CLL (20% of patients with hematological malignancies) with an annual prevalence of 4.35 new cases. The average age of patients was 61 +/- 12,48 years (ranging from 17-85 years); 55 women and 32 men (sex ratio M/F 0.58) were enrolled. Clinically, 16 patients (18%) had no tumor syndrome, 33 patients (38%) had lymphadenopathy, 62 patients (71%) splenomegaly and 23 patients (26%) hepatomegaly. Biologically, the mean blood and medullary lymphocyte count was 87188/mm

Indexed as

AdolescentAdultAgedAged, 80 and overbeta 2-MicroglobulinFemaleHepatomegalyHumansLeukemia, Lymphocytic, Chronic, B-CellL-Lactate DehydrogenaseLymphadenopathyMaleMiddle AgedNeoplasm StagingPrognosisRetrospective Studiesbeta 2-MicroglobulinL-Lactate DehydrogenasebiologyChronic lymphocytic leukemiaclinicalepidemiologyprognosisTogo

Identifiers

PMID31934227
PMCPMC6945677
OpenAlexW3016057745

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.